|

Cetuximab + mFOLFOX6 Clinical Trials

2 actively recruiting trials across 1 location

▲ +1 trial since June 2026

Also known as: 5-FU, Cetuximab or c225, Leucovorin, Oxaliplatin

Pipeline

Phase 2: 2

Top Sponsors

  • Verastem, Inc.1
  • Sun Yat-sen University1

Indications

  • Cancer2
  • Colorectal Cancer1
  • Metastatic Colorectal Cancer1

Other1 trial

Cetuximab and Envafolimab Plus mFOLFOXIRI as First-line Treatment for RAS/BRAF Wild-type, MSS, Unresectable Left-side Metastatic Colorectal Cancer
Phase 2

Los Angeles, California1 trial

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

START Los Angeles

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.